A phase III clinical study of HFT-290 in patients with cancer pain.
Phase of Trial: Phase III
Latest Information Update: 04 Sep 2017
At a glance
- Drugs Fentanyl (Primary)
- Indications Cancer pain
- Focus Adverse reactions; Therapeutic Use
- Sponsors Hisamitsu Pharmaceutical
- 01 Sep 2017 Status changed from recruiting to completed.
- 28 Sep 2016 New trial record